Stock listing
Black Diamond Therapeutics, Inc.
Selected listing: BDTX · BOATS · USD · US
Black Diamond Therapeutics, Inc. (BOATS:BDTX), Health Technology. Latest release Sep 2, 2026: Black Diamond Therapeutics to Participate in H.C. Wainwright…
- Ticker
- BOATS:BDTX
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
About Black Diamond Therapeutics, Inc.
Black Diamond Therapeutics, Inc. is a public company traded under the ticker BDTX in the American market. Black Diamond focuses on developing innovative therapies for various medical conditions.
Latest news from Black Diamond Therapeutics, Inc.
Black Diamond Therapeutics to Participate in H.C. Wainwright 28th Annual Global Investment Conference
September 2, 2026
BioCardia : Aug 24 - BioCardia Announces FDA Confirms Helix Transendocardial Delivery Catheter Meeting Minutes Supporting Follow-on De Novo Pre-submission For Approval
August 24, 2026
Black Diamond Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
August 5, 2026
Black Diamond Therapeutics Announces Positive Phase 2 Results for Silevertinib in Frontline NSCLC Patients with EGFR Non-Classical Mutations
May 21, 2026
Black Diamond Therapeutics to Host Webcast for Investors Highlighting Updated Results from Phase 2 Trial of Silevertinib in 1L EGFRm NSCLC
May 19, 2026
Research Black Diamond Therapeutics, Inc.
Black Diamond Therapeutics, Inc. company profile
View the public company page for Black Diamond Therapeutics, Inc. on 6ix.
Black Diamond Therapeutics, Inc. news
Read company news and market updates connected to Black Diamond Therapeutics, Inc..
Black Diamond Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Black Diamond Therapeutics, Inc..